These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14502491)

  • 21. Sequence, structure and energetic determinants of phosphopeptide selectivity of SH2 domains.
    Sheinerman FB; Al-Lazikani B; Honig B
    J Mol Biol; 2003 Dec; 334(4):823-41. PubMed ID: 14636606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors.
    Marrero-Ponce Y
    J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of solvation sites at the interface of Src SH2 domain complexes using molecular dynamics simulations.
    Geroult S; Hooda M; Virdee S; Waksman G
    Chem Biol Drug Des; 2007 Aug; 70(2):87-99. PubMed ID: 17683370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR analyses of 3-(4-benzylpiperidin-1-yl)-N-phenylpropylamine derivatives as potent CCR5 antagonists.
    Roy K; Leonard JT
    J Chem Inf Model; 2005; 45(5):1352-68. PubMed ID: 16180912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative structure activity relationship of benzoxazinone derivatives as neuropeptide Y Y5 receptor antagonists.
    Deswal S; Roy N
    Eur J Med Chem; 2006 Apr; 41(4):552-7. PubMed ID: 16545499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201.
    Guan P; Doytchinova IA; Walshe VA; Borrow P; Flower DR
    J Med Chem; 2005 Nov; 48(23):7418-25. PubMed ID: 16279801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. QSAR modeling of the interaction of flavonoids with GABA(A) receptor.
    Duchowicz PR; Vitale MG; Castro EA; Autino JC; Romanelli GP; Bennardi DO
    Eur J Med Chem; 2008 Aug; 43(8):1593-602. PubMed ID: 18158201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LQTA-QSAR: a new 4D-QSAR methodology.
    Martins JP; Barbosa EG; Pasqualoto KF; Ferreira MM
    J Chem Inf Model; 2009 Jun; 49(6):1428-36. PubMed ID: 19422246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR method for prediction of protein-peptide binding affinity: application to MHC class I molecule HLA-A*0201.
    Zhao C; Zhang H; Luan F; Zhang R; Liu M; Hu Z; Fan B
    J Mol Graph Model; 2007 Jul; 26(1):246-54. PubMed ID: 17275373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantum mechanical study on phosphotyrosyl peptide binding to the SH2 domain of p56lck tyrosine kinase with insights into the biochemistry of intracellular signal transduction events.
    Pichierri F
    Biophys Chem; 2004 May; 109(2):295-304. PubMed ID: 15110947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative correlation between theoretical molecular descriptors and drug-HSA binding affinities for various cox-2 inhibitors.
    Seedher N; Bhatia S; Singh B
    Chem Biol Drug Des; 2008 Oct; 72(4):297-302. PubMed ID: 18844676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Connecting traditional QSAR and molecular simulations of papain hydrolysis--importance of charge transfer.
    Lepp Z; Chuman H
    Bioorg Med Chem; 2005 May; 13(9):3093-105. PubMed ID: 15809145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QSAR study of 2-(1-Propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide as PARP inhibitors for treatment of cancer.
    Riahi S; Pourbasheer E; Dinarvand R; Ganjali MR; Norouzi P
    Chem Biol Drug Des; 2008 Dec; 72(6):575-84. PubMed ID: 19090924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
    Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
    J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.
    He P; Wu W; Yang K; Jing T; Liao KL; Zhang W; Wang HD; Hua X
    Biopolymers; 2011; 96(3):288-301. PubMed ID: 20690173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
    Nam NH; Ye G; Sun G; Parang K
    J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative structure-activity (affinity) relationship (QSAR) study on protonation and cationization of alpha-amino acids.
    Siu FM; Che CM
    J Phys Chem A; 2006 Nov; 110(44):12348-54. PubMed ID: 17078635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting human plasma protein binding of drugs using plasma protein interaction QSAR analysis (PPI-QSAR).
    Li H; Chen Z; Xu X; Sui X; Guo T; Liu W; Zhang J
    Biopharm Drug Dispos; 2011 Sep; 32(6):333-42. PubMed ID: 21800312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative structure-activity relationship for prediction of the toxicity of polybrominated diphenyl ether (PBDE) congeners.
    Wang Y; Zhao C; Ma W; Liu H; Wang T; Jiang G
    Chemosphere; 2006 Jul; 64(4):515-24. PubMed ID: 16406101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.